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Abstract
The development of a megakaryocyte lineage specific Cre deleter, using the Pf4 (CXCL4) promoter (Pf4-Cre), was a
significant step forward in the specific analysis of platelet and megakaryocyte cell biology. However, in the present study we
have employed a sensitive reporter-based approach to demonstrate that Pf4-Cre also recombines in a significant proportion
of both fetal liver and bone marrow hematopoietic stem cells (HSCs), including the most primitive fraction containing the
long-term repopulating HSCs. Consequently, we demonstrate that Pf4-Cre activity is not megakaryocyte lineage-specific but
extends to other myeloid and lymphoid lineages at significant levels between 15–60%. Finally, we show for the first time
that Pf4 transcripts are present in adult HSCs and primitive hematopoietic progenitor cells. These results have fundamental
implications for the use of the Pf4-Cre mouse model and for our understanding of a possible role for Pf4 in the development
of the hematopoietic lineage.
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Introduction
Cre-loxP technology allows the deletion or expression of genes
to be regulated temporally and spatially in animals [1,2,3,4]. The
nature of a specific promoter used to drive Cre recombinase
expression determines the tissue specificity and timing of
expression. Several tissue-specific Cre deleter strains have been
developed in order to study the effects of conditional gene
expression or deletion in a specific tissue or organ system [2,5,6].
The recent arrival of a megakaryocyte specific Cre driven by the
platelet factor 4 promoter (Pf4-Cre) [7] has significantly impacted
on platelet and megakaryocyte studies [8,9,10]. This mouse model
contributed towards the confirmation of the role of platelets in the
separation of the lymphatic and vasculature systems [8,11].
However, there are reports that endogenous Pf4 is expressed in
cells outside of the megakaryocyte lineage, for example osteoclasts
and monocytes [12,13], suggesting that the Pf4 promoter may not
be specific to the platelet-megakaryocyte lineage.
Here we performed lineage-tracing studies revealing that Pf4-
Cre marks a portion of fetal liver and bone marrow hematopoietic
stem cells (HSCs) and their downstream progeny. Consistent with
this, we show that Pf4 transcripts are present in HSCs and
primitive hematopoietic cells. Taken together, these results provide
genetic evidence that Pf4-Cre does not recombine solely in the
megakaryocyte lineage but in addition in a large proportion of
stem and progenitor cells and all their progeny. Therefore, our
results imply that hematopoietic phenotypes of conditional
mutations generated using the Pf4-Cre deleter must be interpreted
with caution. These observations additionally indicate a possible
role for PF4 in haematopoietic stem or progenitor function, which
merits future investigation.
Materials and Methods
Transgenic Mice
All experiments were carried out according to UK Home Office
regulations. We crossed Pf4-Cre transgenic mice [7] with mice
containing a conditional tandem dimer RFP (tdRFP) construct
under the control of the Rosa26 promoter [14]. Rosa26-
tdRFP2;Pf4-Cre+ and Rosa26-tdRFP+;Pf4-Cre2 mice were used
as controls. The Rosa26-tdRFP+;Pf4-Cre+mice were heterozygous
at the Rosa26-tdRFP locus.
Flow Cytometry
Cells were stained as previously described [15,16]. Platelets and
megakaryocytes were isolated from the peripheral blood and the
bone marrow according to standard procedures [17,18]. FACS
analysis was performed using the FACSCanto Flow Cytometer
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and cell isolation was performed using the FACSAria II cell sorter
(Becton Dickinson, UK) and analysed using FlowJo software (Tree
Star Incorporation, USA).
qPCR
For qPCR, whole bone marrow was stained with antibodies
against a lineage cocktail, Sca-1, c-kit and isolated based on
CD150 and CD48 staining. Single cells were sorted using the cells
direct one-step qRT-PCR kit (Life Technologies, USA) and gene
expression carried out on a Fluidigm chip (Fluidigm, USA) with
Taqman probes (Life Technologies, USA). Beta-2-Microglobulin
was used as the housekeeping control. The Lin2Sca-1+c-kit+ (LSK)
CD150+CD482 HSC population (defined as the most primitive
HSC fraction or Long-term HSC (LT-HSC)) was used as a
calibrator and set to the value of 1. The fold change of Pf4 in all
other populations was in comparison to LT-HSC population. The
data were calculated using the Delta Delta CT method for qPCR
analysis [15,16].
Histology
Mouse femur and tibia were removed and placed either in ice-
cold formalin for overnight fixation (quick fix) or room-temper-
ature for long fixation, and then processed into paraffin blocks.
Tissue sections were then cut, and processed for RFP immuno-
histochemistry. Slides were de-waxed for 2610 min washes in
xylene, and then hydrated by washing in decreasing concentra-
tions of alcohol 100%, 95%, and 70% for 3 mins, followed by a
final wash in tap water. The antigen is retrieved by boiling slides in
citrate buffer pH6 for 4 min in a microwave. The slides were
cooled, before rinsing in dH2O, and blocked with 3% hydrogen
peroxide for 15 min, followed by 3 washes in TBS-T/
0.05%Tween. The slides were blocked for 1 hr with 5% goat
serum, and incubated overnight at 4uC with 1/200 RFP antibody
(Abcam, Cambridge, UK). Slides were then washed before
addition of secondary antibody following the Envision HRP kit
protocol (Dako, Cambridge, UK). The slides were visualized for
2 min before termination with dH2O. The slides were counter-
stained with Meyers Haematoxylin before mounting.
Figure 1. Pf4-Cre efficiently excises floxed sequences in megakaryocytes and platelets. (A) Platelets from both Rosa26-tdRFP+;Pf4-Cre2
litter matched control and Rosa26-tdRFP+;Pf4-Cre+ mice were isolated from whole blood before being stained with anti-CD41-FITC antibody. The
level of RFP expression in the platelet (CD41+) population was identified. (B) Bone marrow megakaryocytes were isolated before being stained with
anti-CD41-FITC antibody. Megakaryocytes were identified using FSC vs SSC gating and the levels of RFP expression in the megakaryocyte population
was determined. Dot plots are representative figures of three independent experiments with the mean6standard error of the mean (SEM).
doi:10.1371/journal.pone.0051361.g001
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Results and Discussion
To perform lineage tracing of Pf4-Cre we crossed Pf4-Cre
transgenic mice with mice containing a conditional loxP flanked
NEO-STOP-tdRFP under the control of the Rosa26 promoter
[14]. First we confirmed efficient Pf4-Cre-mediated recombination
in platelets and megakaryocytes. As expected almost all platelets
Figure 2. Pf4-Cre activates RFP expression in all hematopoietic lineages. (A) Frequencies of RFP-expressing B-lymphoid (CD19+), myeloid
(Gr-1+), and erythroid (Ter119+) cells in the bone marrow obtained from adult Rosa26-tdRFP+;Pf4-Cre+ mice and Rosa26-tdRFP+;Pf4-Cre2 litter
matched controls. (B) Frequencies of RFP-expressing B-lymphoid (CD19+), myeloid (Gr-1+), and erythroid (Ter119+) cells in the spleen from adult
Rosa26-tdRFP+;Pf4-Cre+ mice and Rosa26-tdRFP+;Pf4-Cre2 litter matched controls. (C) Frequencies of RFP-expressing CD4+ T cells in the spleen and
thymus of adult Rosa26-tdRFP+;Pf4-Cre+ mice and Rosa26-tdRFP+;Pf4-Cre2 litter matched controls. Dot plots shown in Figure 1A–C are representative
figures of 3–5 independent experiments with values shown as an average6SEM from 3–5 independent experiments. % of RFP+ cells is indicated in
red and % of RFP2 in black. (D) Bone marrow from Rosa26-tdRFP+;Pf4-Cre+ and litter matched controls was fixed, and histologically stained for RFP.
Images are representative of 2 independent experiments.
doi:10.1371/journal.pone.0051361.g002
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from Rosa26-tdRFP+;Pf4-Cre+ adult mice expressed RFP
(Fig. 1A). The analysis of the megakaryocyte population isolated
from the bone marrow of Rosa26-tdRFP+;Pf4-Cre+ mice revealed
that over 53.563.7% of cells expressed RFP (Fig. 1B). This result
is lower than that seen by Tiedt et al but this is likely to be due to
the presence of immature megakaryocytes which have not yet
undergone recombination and also those that will need time to
switch on RFP expression. However, our data indicate that all
mature platelet producing megakaryocytic have undergone
recombination as expected. Indeed even Tiedt et al identified
that in the megakaryocyte population integrin b1 was not
completely deleted in integrinb1flox/floxPf4-Cre+ indicating that
possibly not all purified megakaryocytes have yet undergone
recombination.
Next, we determined if Pf4-Cre was activated outside the
megakaryocyte/platelet lineage. The analysis of Rosa26-
tdRFP+;Pf4-Cre+ adult mice (3–9 months of age) revealed RFP
expression in 43.5610.5% mature B-lymphoid (CD19+),
35.368.4% myeloid (Gr-1+) and 14.763% erythroid (Ter119+)
bone marrow lineages (Fig. 2A) in comparison to controls. Further
analysis of the Rosa26-tdRFP+;Pf4-Cre+ spleens indicated
37.969.7% mature B cells, 32.166.8% myeloid, 1462.9%
erythroid and 33.4610.3% T cells (CD4+ cells) with RFP
expression, whilst in the thymus 43.6612.4% T cells had RFP
expression (Fig. 2B&C). This expression of RFP outside the
megakaryocyte lineage was confirmed by immunostaining for RFP
expression in bone marrow histology samples (Fig. 2D). Our flow
cytometry analysis indicates RFP+ populations in all mature blood
lineages, demonstrating that Pf4-Cre activity is not restricted to the
megakaryocytic lineage.
The multilineage expression of RFP in Rosa26-tdRFP+;Pf4-
Cre+ mice suggested that Pf4-Cre could be active in either
primitive progenitors or HSCs. Analysis of the Lin2c-kit+ (LK)
compartment, which contains the common myeloid progenitor
(CMP), granulocyte myeloid progenitor (GMP) and megakaryo-
cyte-erythrocyte progenitor (MEP) cell populations, contained just
over 50% of RFP expressing cells (Fig. 3A). The frequency of
RFP+ cells in the MEP, CMP and GMP populations was
65.862.1%, 64.466.6% and 66.366.2% respectively (Fig. 3B).
Further analyses of Rosa26-tdRFP+;Pf4-Cre+ mice showed signif-
icant RFP expression in the LSK compartment, which contains
the LT-HSCs, short-term HSCs (ST-HSCs), and lymphoid
primed multipotent progenitors (LMPPs). On average
54.866.4% of cells in the LSK compartment expressed RFP
(data not shown). To identify the most primitive hematopoietic cell
type that expresses Pf4, we subfractionated the LSK compartment
Figure 3. Pf4-Cre genetically marks the adult stem cell and early progenitor cell compartment. Bone marrow from Rosa26-tdRFP+;Pf4-
Cre+ and litter matched control mice was isolated and (A) the Sca-12c-kit+ cells identified in the Lin2 cell compartment. LK compartment was
subfractionated using side scatter (SSC) and RFP expression to identify the total number of RFP2 (black) and RFP+ (red) cells. (B) The LK population
was subfractionated using CD34 and CD16/32 to identify RFP+ (red) cells in the megakaryocyte-erythrocyte progenitor (MEP) (Compartment I),
common myeloid progenitor (CMP) (Compartment II) and granulocyte-macrophage progenitor (GMP) (Compartment III) cell populations. (C) RFP
expression in HSCs and primitive progenitors in the LSK compartment. The LSK cell compartment was subfractionated using CD48 and CD150 to
identify the frequencies of RFP+ (red) cells in LSK CD150+CD482 HSC (Compartment I), LSK CD1502CD482 (Compartment II), LSK CD150+CD48+
(Compartment III) and LSK CD1502CD48+ (Compartment IV) compartments. Dot plots and histograms are representative figures of three
independent experiments with the mean6SEM from three independent experiments.
doi:10.1371/journal.pone.0051361.g003
Pf4-Cre Marks Hematopoietic Stem Cells
PLOS ONE | www.plosone.org 4 December 2012 | Volume 7 | Issue 12 | e51361
of Rosa26-tdRFP+;Pf4-Cre+ mice using CD150 and CD48
staining. Our data indicated that 40.569.4% of LSK
CD150+CD482 HSCs (LT-HSCs) expressed RFP (Fig. 3C).
Furthermore, the downstream progeny of LT-HSCs, ST-HSCs
(CD1502CD482:Compartment II), MPP1 (CD150+CD48+:Com-
partment III), and MPP2 (CD1502CD48+:Compartment IV) all
expressed RFP (Fig. 3C). Reanalysis of the LSK and LK
compartments with a CD41 gate to remove possible platelet
contamination identified 55.662.8% of CD412 cells were RFP+
in the LSK compartment whilst in the LK compartment
55.662.1% of CD412 cells were RFP+ (data not shown).
Therefore, RFP expression in the stem cell and progenitor
compartments is not due to contamination from a platelet or
megakaryocyte population. These immunophenotypic analyses
demonstrated that Pf4-Cre exhibits its activity in the most
primitive compartment of the adult hematopoietic differentiation
hierarchy.
Next, we determined whether Pf4-Cre also marks fetal HSCs.
Immunophenotypic analyses of fetal liver from 15.5 dpc Rosa26-
tdRFP+;Pf4-Cre+ and control embryos revealed there was also a
significant population of RFP+ cells in the LK compartment
(Fig. 4A). This RFP expression was replicated in the LSK
compartment with RFP expression in 12.260.6% of LSK cells
(data not shown). Furthermore, 962.5% of LSK CD150+CD482
HSCs expressed RFP (Fig. 4B). As the LT-HSCs became ST-
HSCs and LMPPs, there was an increase in RFP expression in
these compartments (Fig. 4B). These data indicate that the Pf4-Cre
transgene is activated in fetal liver HSCs during embryonic
development.
The presence of RFP in HSCs and their progeny raised a
question of whether the endogenous Pf4 gene might also be
expressed in the most primitive hematopoietic cells. To address
this, we determined the expression of endogenous Pf4 in LSK
CD150+CD482 HSCs (LT-HSCs) isolated from genetically
normal mice, and their immediate downstream progeny (LSK
CD1502CD482, LSK CD150+CD48+and LSK CD1502CD48+
cells) using qPCR. These analyses revealed that endogenous Pf4
transcripts are present in all tested populations of the LSK
compartment (Fig. 5). The presence of endogenous Pf4 mRNA in
HSCs and primitive progenitor cells reflects the transcriptional
activity of the Pf4 promoter in these populations and, at least in
part, explains the multilineage expression of RFP in Rosa26-
tdRFP+;Pf4-Cre+ mice.
We demonstrate that Pf4-Cre is activated not only in the
megakaryocyte lineage but additionally in approximately 50% of
stem and primitive progenitor cell compartments. This leads to
expression of the RFP reporter in all hematopoietic lineages of the
Figure 4. Primitive fetal liver cells from Rosa26-tdRFP+;Pf4-Cre+ mice express RFP. Fetal liver from day E14.5 Rosa26-tdRFP+;Pf4-Cre+ and
litter matched controls was isolated and (A) the Sca-12c-kit+ cells identified in the Lin2 cell compartment. LK compartment was subfractionated using
side scatter (SSC) and RFP expression to identify the total number of RFP2 (black) and RFP+ (red) cells. Dot plots are representative figures of three
independent experiments with the average6SEM from three independent experiments. (B) RFP expression in HSCs and primitive progenitors within
the LSK compartment. The LSK cell compartment was subfractionated using CD48 and CD150 to identify the frequencies of RFP+ (red) in LSK
CD150+CD482 HSC (Compartment I), LSK CD1502CD482 (Compartment II), LSK CD150+CD48+ (Compartment III) and LSK CD1502CD48+
(Compartment IV) compartments. Dot plots and histograms are representative figures of three independent experiments with the mean6SEM from
three independent experiments.
doi:10.1371/journal.pone.0051361.g004
Figure 5. Pf4 gene expression is identified in Stem and
primitive progenitor cell populations. Pf4 expression in LSK
CD150+CD482 HSCs, LSK CD1502CD482, LSK CD150+CD48+, and LSK
CD1502CD48+ cells sorted from bone marrow of control mice. Relative
Pf4 expression levels were calculated with the LT-HSC fraction set to the
value of 1 (see methods). Results are mean6SD from three independent
experiments.
doi:10.1371/journal.pone.0051361.g005
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Rosa26-tdRFP+;Pf4-Cre+ mice. In agreement with our data,
Chagraoui et al used semi-quantitative PCR to identify between
30–50% recombination in CMP, GMP and MEP progenitors in
SCLfx/fxPf4iCre+ mice [19]. However, Tiedt et al [7] and Bertozzi
et al [8] have inferred the specificity of the Pf4-Cre to the
megakaryocyte lineage through the use of histology and immuno-
staining. We believe there are technical reasons why these results
differ to our results. Histology, in our hands showed variable
staining, depending on whether a long fixation or quick fixation
protocol was used. Secondly, the mouse model we have used
contains a tandem RFP. This reporter has increased fluorescence
intensity in comparison to other reporter mice [14], and therefore
may be more sensitive for identifying expression in other
compartments than either the LacZ or YFP reporters.
Our data indicate that the Pf4 expression is not restricted to the
megakaryocytic/platelet lineage and is also present in HSCs and
their primitive progeny. This observation, taken together with the
expression of another megakaryocytic/platelet lineage-associated
gene VWf [20] in self-renewing HSCs fits the model in which
HSCs express individual lineage-affiliated genes [21]. The
functional significance of the expression of megakaryocytic/
platelet lineage-associated genes in HSCs remains an open
question meriting future investigations.
Finally, our results provide genetic evidence indicating that
hematopoietic phenotypes of conditional mutations generated
using the Pf4-Cre deleter must be interpreted in light of Pf4-Cre
activation outside the megakaryocyte lineage. It is fundamental to
understand the effect of this leakiness outside the megakaryocyte
lineage in each conditional mouse used to be able to fully interpret
results obtained from the use of the Pf4-Cre mouse model system.
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